Drug Type Immune stimulating antibody conjugate (ISAC) |
Synonyms- |
Target |
Mechanism HER2 modulators(Receptor protein-tyrosine kinase erbB-2 modulators), TLR9 antagonists(Toll like receptor 9 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC12H16N2O3 |
InChIKeyIBLSXJXHUXUHIM-UHFFFAOYSA-N |
CAS Registry104676-09-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 13 Mar 2023 |